Melinda Charrier
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 07, 2020
IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment.
Journal: Journal for immunotherapy of cancer
Published: April 07, 2020
Circulating innate immune markers and outcomes in treatment-naïve advanced non-small cell lung cancer patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 31, 2018
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer.
Journal: JAMA oncology
Published: January 13, 2018
Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patients.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 28, 2017
Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.
Journal: Journal of Crohn's & colitis
Published: January 11, 2017
Dendritic cell-derived exosomes as immunotherapies in the fight against cancer.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 23, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026